| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 1.888 | 5.628 | 7.759 | 9.284 | 6.377 | 8.319 | 7.775 | 2.294 | 0 |
| Total Income - EUR | - | 1.888 | 5.628 | 7.759 | 9.284 | 6.377 | 8.319 | 7.775 | 2.294 | 0 |
| Total Expenses - EUR | - | 109 | 125 | 208 | 364 | 722 | 362 | 403 | 228 | 68 |
| Gross Profit/Loss - EUR | - | 1.779 | 5.503 | 7.551 | 8.920 | 5.655 | 7.956 | 7.372 | 2.066 | -68 |
| Net Profit/Loss - EUR | - | 1.722 | 5.334 | 7.318 | 8.641 | 5.473 | 7.707 | 7.139 | 1.735 | -68 |
| Employees | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Medicol Rx 26 Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | 1.820 | 5.553 | 7.712 | 11.110 | 11.248 | 13.243 | 7.704 | 4.140 | 329 |
| Inventories | - | 18 | 17 | 17 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 0 | 0 | 0 | 0 | 0 | 0 | 5.742 | 11 | 11 |
| Cash | - | 1.802 | 5.536 | 7.695 | 11.110 | 11.248 | 13.243 | 1.962 | 4.128 | 318 |
| Shareholders Funds | - | 1.767 | 5.378 | 7.547 | 10.879 | 10.977 | 12.983 | 7.387 | 3.844 | 35 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 53 | 176 | 165 | 231 | 271 | 260 | 317 | 296 | 294 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Medicol Rx 26 Srl